Total | Normal | Prehypertension | Stage 1 | Stage 2 | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
n | Per cent | SE | n | Per cent | SE | n | Per cent | SE | n | Per cent | SE | ||
ENGLAND | |||||||||||||
All | 7382 | 2528 | 34.2 | 0.7 | 3242 | 43.9 | 0.7 | 1235 | 16.7 | 0.5 | 376 | 5.1 | 0.3 |
Sex | |||||||||||||
Males | 3555 | 761 | 21.4 | 0.8 | 1903 | 53.5 | 0.9 | 709 | 19.9 | 0.7 | 182 | 5.1 | 0.4 |
Females | 3826 | 1767 | 46.2 | 0.9 | 1339 | 35 | 0.9 | 526 | 13.7 | 0.6 | 195 | 5.1 | 0.4 |
Age | |||||||||||||
20–39 | 2618 | 1273 | 48.6 | 1.2 | 1115 | 42.6 | 1.1 | 210 | 8 | 0.6 | 20 | 0.8 | 0.2 |
40–59 | 2962 | 966 | 32.6 | 0.9 | 1360 | 45.9 | 0.9 | 482 | 16.3 | 0.7 | 155 | 5.2 | 0.4 |
60–79 | 1801 | 289 | 16.1 | 1 | 767 | 42.6 | 1.5 | 543 | 30.2 | 1.3 | 201 | 11.2 | 0.9 |
CANADA | |||||||||||||
All | 3485 | 2214 | 66.1 | 1.7 | 955 | 27.2 | 1.4 | 259 | 5.4 | 0.3 | 57 | 1.3* | 0.2* |
Sex | |||||||||||||
Males | 1649 | 951 | 60.6 | 2.4 | 538 | 32.9 | 2.2 | 140 | 5.9 | 0.5 | 20 | 0.7* | 0.2* |
Females | 1836 | 1263 | 71.6 | 1.4 | 417 | 21.6 | 1.1 | 119 | 4.8 | 0.6 | 37 | 2.0* | 0.5* |
Age | |||||||||||||
20–39 | 1159 | 992 | 84.0 | 1.9 | 155 | 15.2 | 1.8 | † | † | † | † | † | † |
40–59 | 1231 | 785 | 63.4 | 3.3 | 351 | 30.2 | 2.8 | 81 | 5.3 | 0.7 | 14 | 1.1* | 0.3* |
60–79 | 1095 | 437 | 39.4 | 2.0 | 449 | 42.9 | 2.2 | 168 | 13.8 | 1.1 | 41 | 3.9* | 1.0* |
USA | |||||||||||||
All | 10 003 | 4663 | 50.3 | 0.8 | 3615 | 36.0 | 0.7 | 1296 | 11.0 | 0.4 | 429 | 2.7 | 0.2 |
Sex | |||||||||||||
Males | 5033 | 1998 | 42.2 | 1.0 | 2109 | 42.7 | 1.0 | 713 | 12.2 | 0.6 | 213 | 2.8 | 0.3 |
Females | 4970 | 2665 | 58.3 | 1.0 | 1506 | 29.3 | 0.8 | 583 | 9.7 | 0.5 | 216 | 2.7 | 0.2 |
Age | |||||||||||||
20–39 | 3394 | 2210 | 65.2 | 1.1 | 1007 | 29.7 | 1.1 | 148 | 4.4 | 0.4 | 29 | 0.7 | 0.1 |
40–59 | 3586 | 1608 | 46.5 | 1.3 | 1371 | 39.1 | 1.1 | 473 | 11.9 | 0.7 | 134 | 2.6 | 0.3 |
60–79 | 3023 | 845 | 30.8 | 1.3 | 1237 | 41.3 | 1.2 | 675 | 21.2 | 1.1 | 266 | 6.7 | 0.5 |
*Interpret with caution (coefficient of variation 16.6–33.3%).
†Too unreliable to be reported (coefficient of variation greater than 33.3%).
Normal: Systolic<120 and diastolic<80. Prehypertension: 120≤systolic<140 or 80≤diastolic<90. Stage 1: 140≤systolic<160 or 90≤diastolic<100. Stage 2: systolic≥160 or diastolic≥100. Regardless of medication use.